Orthopedic Biologics Supplier Serving Akron, Ohio Practices

Account setup starts with NPI verification

Precision Biologics requires a valid NPI number before opening an account, which limits orders to licensed physicians and clinics operating under physician supervision. Orthopedic practices and surgery centers in Akron complete this step the same way as any other licensed account, regardless of practice size.

This verification step mirrors the same NPI registry used to produce the provider count referenced earlier on this page.

What orthopedic practices typically review before adding a vendor

Orthopedic groups commonly review a new biologics supplier's documentation, licensure status, and shipping process before adding it to an approved vendor list, with a medical director or designated staff member signing off. Precision Biologics supports that review by making registration and licensure documentation, along with lot-specific paperwork, available to verified accounts.

This review step does not involve an evaluation of clinical outcomes, since Precision Biologics does not make outcome or efficacy claims about its products.

Cold-chain shipping to the Midwest

Cryopreserved products are stored at -80 degrees C prior to shipment and travel overnight on dry ice in validated containers. Orthopedic practices in Akron, part of the Midwest region, should have a receiving process in place to move a shipment into proper storage promptly after it arrives.

Lyophilized Wharton's jelly and exosome formats are shelf-stable and ship with a product insert describing storage and, where applicable, reconstitution handling.

Documentation, regulatory review, and ongoing support

Each lot is quarantined until third-party sterility testing and internal release criteria are met, and carries a unique lot identifier for traceability at the clinic's patient-record level. A certificate of analysis, donor eligibility summary, and lot release record are available on request.

Precision Biologics does not advise on dosing, protocols, or how a specific intended use is classified under federal regulation; practices should confirm their own regulatory posture with the Ohio medical board and independent counsel. Precision Biologics supports account setup with access to physician-level conversations focused on documentation.

FDA has stated there are no FDA-approved exosome products. Exosome products are generally regulated as biologic drugs under section 351 of the Public Health Service Act, not as 361 HCT/Ps. Purchase and clinical use decisions belong to the physician with their own regulatory counsel.

These products are not FDA approved or licensed for any disease or condition. Information is for licensed healthcare professionals and is not medical or legal advice.